Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 7 of 25
Embedded Primary Care MultiDisciplinary Diabetes Clinic
NCT06015685
Everyday Activity Shoes: a Quantification of Impact Forces While Walking
NCT04197362
Methylprednisolone Taper After Total Knee Replacement
NCT05859269
Web-based Physical Activity Intervention to Promote Physical Activity
NCT05803304
Systems Biological Assessment of Statin Effect on Vaccine Responses
NCT06024096
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
NCT05733351
Sugammadex as Rescue Therapy
NCT05661409
Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy
NCT05256901
Coaching for Advanced Practice Providers
NCT05938556
Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
NCT05502107
Development and Adaptation of I-STRONG for SCD
NCT06110754
Doxy-Post-exposure Prophylaxis
NCT05853120
Sentinel Cohort REACT
NCT05780801
Telehealth Delivery (Tele-B6)
NCT05829759
Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
NCT05743946
Lidocaine Administration Using STAR Particles
NCT06034340
Brain Stimulation and Visually-guided Navigation
NCT04961645
Keeping on Course: A Communication-Focused Psychoeducational Program
NCT05423912
Trigger Finger Trial
NCT05251428
InPART RX - Epicenters
NCT07368660
Medial Peel Release Technique TKA Randomized Clinical Trial
NCT05154058
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
NCT05506982
Education Program for Caregivers of Children With Gross Motor Delays
NCT05542251
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
NCT04522739
A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening
NCT05526872
TBI Evaluation and Management (TEaM)
NCT04576715
Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
NCT05741489
Improving Women's Health Through Coordinated Postpartum Planning
NCT05430815
Improving Sleep and Cognition in Alzheimer's Disease
NCT05200208
Incorporating CV Risk Assessment in AYA Visits
NCT05384834
Education Tools to Support Pediatric Survivor Care
NCT04257058
Mental Health Resources for Frontline Healthcare Workers
NCT05113316
Pharmacy-based Pre-exposure Prophylaxis
NCT04393935
Carepartner Collaborative Integrated Therapy Gait (CARE-CITE-Gait) Program
NCT05257928
Caregiver Adverse Childhood Experiences (ACEs) in Pediatric Primary Care
NCT05013138
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy
NCT05250895
Levodopa for Diabetic Retinopathy
NCT07444892
Better Together Study
NCT05275231
Innovative Biofeedback Interface for Enhancing Stroke Gait Rehabilitation
NCT04013971
F-18 PSMA for Localization of Parathyroid Adenoma
NCT05299632
Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer
NCT05346692
The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia
NCT05018728
Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant
NCT05274763
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
NCT05035862
Preoperative Education in Hand and Wrist Surgery
NCT05237531
Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain
NCT05254379
Stress in Inflammatory Bowel Disease
NCT05202418
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT03772717
Mobile HIV Prevention App for Black Women
NCT05080972
SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes
NCT05256706
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Emory University pipeline card: 1,208 registered trials from official public datasets.Report a data error.